NHS priorities

Whether it’s to prepare for the next Quality Payments Scheme deadline, or to increase your confidence in helping people with a learning disability, this section provides topic-specific pages that link to current NHS priorities. This section will support you in keeping your knowledge and skills up to date in order to provide high-quality pharmacy services and be service-ready.

Clinical pharmacy

Our clinical portfolio is expanding on a frequent basis, helping you to advance your knowledge and skills and deliver medicines optimisation in practice for all sectors of pharmacy. From two new focal points a year to our small group learning for hospital pharmacists – Optimise – this section focuses on clinical pharmacy, diseases and therapeutics.

Public health

The public health agenda is embedded in pharmacy, yet topics such as emergency contraception or stop smoking support are as prevalent as ever. As well as our public health workshops, use this section to access a wide range of resources to assure and maintain your competence, all underpinned by the Declaration of Competence system.

CPPE Optimise programmes

Best-value biological medicines: Focus on the position of biosimilar medicines

Released: 14/07/2020

Background learning

This programme consists of a combination of interactive, online and small group learning activities. Click through the screens to complete the programme.

The Best-value biological medicines: Focus on the position of biosimilar medicines Optimise programme assumes you have some prior knowledge of the topic area. You may wish to watch the two short videos below to revise your knowledge before you start the Optimise programme.

Once you have completed the programme, or if you want to skip this section, click Next to continue.

Content contributors

Dale Arm-Riding, patient
Idris Bobat, pharmacy homecare lead and medication safety, Gloucestershire Hospitals NHS Foundation Trust
Stephen Brown, regional pharmacist, NHS England/NHS Improvement, South West and South East England
Anna Pracz, senior medicines optimisation pharmacist, Greater Manchester Health and Care Commissioning
Vanessa Reid, lead specialist clinical pharmacist, specialist medicine (dermatology, immunology, gastroenterology and rheumatology), Manchester University Foundation Trust
Caron Underhill, biologics pharmacist, University Hospital Southampton NHS Foundation Trust

CPPE programme developer

Liz Reid, lead pharmacist, learning development

CPPE reviewers

Samantha White, deputy director
Karen Wragg, regional manager, South Central

External reviewers

Clare Hardy, senior pharmacist – biologics, Chesterfield Royal Hospital NHS Foundation Trust
Sally James, divisional lead pharmacist for unscheduled care, Royal Liverpool University Hospital

CPPE editor

Paddy McLaughlin, editor

Piloted by

Alison Fryer, Salford Royal NHS Foundation Trust
Bilal Jabbar, Avicenna Medical Practice, Bradford

Brand names and trademarks

CPPE acknowledges the following brand names and registered trademarks mentioned throughout this update: Benepali ®, Enbrel ®, Hulio ®, Humira ®

References

  1. NHS England. Medicines Value Programme. www.england.nhs.uk/medicines/value-programme/
  2. Medicines and Healthcare products Regulatory Agency. Drug Safety Update. Biosimilar products. Feb 2008; Vol 1, Issue 7: 8. www.gov.uk/drug-safety-update/biosimilar-products/
  3. Medicines and Healthcare products Regulatory Agency. Black triangle scheme. 2019. www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals#black-triangle-scheme
  4. Medicines and Healthcare products Regulatory Agency. Drug Safety Update. Reporting suspected adverse drug reactions to vaccines and biological medicines. November 2012, vol 6, issue 4: H1. www.gov.uk/drug-safety-update/reporting-suspected-adverse-drug-reactions-to-vaccines-and-biological-medicines
  5. NHS England. What is a biosimilar medicine? 2019. www.england.nhs.uk/publication/what-is-a-biosimilar-medicine/